Related Experiment Video
Updated: Jun 15, 2026

05:16
Multiplexed Fluorescent Immunohistochemical Staining of Four Endometrial Immune Cell Types in Recurrent Miscarriage
Published on: August 4, 2021
Hypo-osmotic swelling test and unexplained repeat early pregnancy loss
1Department of Obstetrics and Gynecology, Vivekananda Institute of Medical Sciences, and S.C. Das Memorial Medical and Research Center, Jodhpur Park, Kolkata, India. drsudhindra54@gmail.com
The Journal of Obstetrics and Gynaecology Research
|February 25, 2010
Summary
The hypo-osmotic swelling (HOS) test may help identify paternal factors in recurrent early pregnancy loss. Lower HOS test scores in men with a history of pregnancy loss suggest its utility in clinical settings.
Area of Science:
- Reproductive Medicine
- Andrology
- Genetics
Background:
- Recurrent unexplained early pregnancy loss affects numerous couples.
- Identifying paternal factors is crucial for effective management.
- Standard semen parameters do not always correlate with reproductive success.
Purpose of the Study:
- To investigate the association between sperm characteristics, including the hypo-osmotic swelling (HOS) test, and repeat unexplained early pregnancy loss.
- To evaluate the HOS test as a potential screening tool for paternal contributions to pregnancy loss.
Main Methods:
- Semen analysis using World Health Organization criteria was performed on 74 men with a history of repeat early pregnancy loss (Group A).
- A hypo-osmotic swelling (HOS) test was conducted on all participants.
- Semen samples from 65 men with proven fertility (Group B) served as controls.
Main Results:
- No significant differences were found in sperm concentration, morphology, or motility between Group A and Group B.
- Mean HOS test scores were significantly lower in Group A (60.4%) compared to Group B (76.9%) (P=0.01).
- Low HOS test scores were observed in 33.8% of men in Group A versus 12.3% in Group B.
Conclusions:
- The sperm HOS test may serve as a valuable tool for screening paternal factors contributing to recurrent embryonic or early fetal loss.
- The HOS test is a cost-effective and potentially useful diagnostic method, especially in resource-limited settings.
- This test can be implemented in standard clinical laboratories for enhanced fertility assessment.
